What it is
Importance: Information on the effects of tirzepatide, a once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist approved for obesity management in adults with obesity, remains limited in adolescents.
Every metric behind this entry is listed, with its source, under Sources and data below.
Filed underPharmacology and Obesity Treatment, Obesity, Physical Activity, Diet, Bariatric Surgery and Outcomes